Saturday, December 6, 2014

Is Competition for Sun's Liposomal doxorubicin in the US on the anvil!

Dr. Reddy has initiated a bioeqivalence trial comparing its generic version of Liposomal doxorubicin to Sun pharma's generic copy of Liposomal doxorubicin. The study will complete in February 2015. It is speculated that Dr. Reddy has partnership with Natco Pharma for the development of liposomal doxorubicin. If everything falls in place in time an approval for Reddy's generic copy of liposomal doxorubicin should come in as early as YE 2015.
Enter your email address:


Delivered by FeedBurner

Wednesday, November 19, 2014

Dr. Reddy gets USFDA Approval to market copies of OTC Allegra D

The USFDA has granted approval to Dr.Reddy for marketing OTC and generic version of combination pill -fexofenadine hydrochloride - pseudoephedrine hydrochloride (Allegra - D 12 hrs). Allegra-D 12 Hour is nasal decongestant and is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older.
For the 9 month ending September 2014, Allegra family had annual sales of approximately $150million

Enter your email address:


Delivered by FeedBurner

Saturday, November 8, 2014

Tata Motors - Jaguar Land rover UK sales for October 2014 decline despite a robust growth in the overall car sales in UK

Jaguar Land Rover Sales in UK for the month of October declined 1.7 percent. The decline was primarily driven by a dip in Land rover sales. Land rover sales which comprise bulk of JLR sales declined almost 7 percent. Jaguar sales were up 19 percent from 944 units to 1127. Land rover sales declined from 3965 to 3695 units.

The dip is JLR sales is disappointing as new car sales in UK  were 14.2% higher in October than a year earlier. 179,714 vehicles were registered in UK in the month of October.The Ford Fiesta, Ford Focus, and Vauxhall Corsa were the top three bestselling models in October and the year so far. The UK auto manufacturer association is expecting car sales to jump 8.1% over the year as a whole to 2.45m, underpinned by cheap finance deals and a better-than-expected economic backdrop, with unemployment falling faster and consumer confidence at higher levels




Enter your email address:


Delivered by FeedBurner

Monday, November 3, 2014

Tata Motors October 2014 Jaguar Land Rover (JLR) sales in the US disappoint

Jaguar Land Rover  Sales for October 2014 in the US were disappointing.  JLR sales declined 20 percent on a year over year basis. According to JLR the sales decline was primarily because of poor inventory planning. Even sales of  Land Rover which so far has continued to grow declined 15 percent.  Jaguar Sales were just  1007 which is 34 percent down year over year.
The slow  down in JLR sales is all the more disappointing as the automative industry in the US  maintained its strong growth. On a year till date basis, automative sales grew 6.1 percent. The industry added 16.46 new vehicles this year versus 15.38 million vehicles in the corresponding period last year.  In October there  were 1.28 million new cars and trucks in the U.S. Trucks, vans and SUVs accounted for 52% of sales, continuing to outsell cars
 
 



Enter your email address:


Delivered by FeedBurner

Wednesday, October 1, 2014

TATA MOTORS - JAGUAR LAND ROVER US SALES DECLINE IN SEPTEMBER 2014

US Sales for Jaguar Land rover brands declined in September 2014 while the industry sales grew by a whooping 9 percent. Total sales for Jaguar and Land rover brands were down 9.6 percent. Jaguar sales fell 13.6 percent (1142 vs. 1313 ) while land rover sales were down 8.3 percent (  3106 vs 3387 ). US sales comprise approximately 15 percent of Tata Motor's JLR sales.


Enter your email address:


Delivered by FeedBurner